EE200000429A1 - Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid - Google Patents

Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE200000429A1
EE200000429A1 EEP200000429A EE200000429A1 EE 200000429 A1 EE200000429 A1 EE 200000429A1 EE P200000429 A EEP200000429 A EE P200000429A EE 200000429 A1 EE200000429 A1 EE 200000429A1
Authority
EE
Estonia
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
synthetic polysaccharides
Prior art date
Application number
Other languages
English (en)
Inventor
Johannes Egbertus Maria Basten
Cornelia Maria Dreef-Tromp
Pierre-Alexandre Driguez
Philippe Duchaussoy
Jean-Marc Herbert
Maurice Petitou
Constant Adriaan Anton Van Boeckel
Original Assignee
Sanofi Synthelabo
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo, Akzo Nobel Nv filed Critical Sanofi Synthelabo
Publication of EE200000429A publication Critical patent/EE200000429A/et
Publication of EE200000429A1 publication Critical patent/EE200000429A1/et
Publication of EE04157B1 publication Critical patent/EE04157B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
EEP200000429A 1998-01-19 1999-01-13 Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid EE04157B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800515A FR2773804B1 (fr) 1998-01-19 1998-01-19 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
PCT/FR1999/000044 WO1999036443A1 (fr) 1998-01-19 1999-01-13 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant

Publications (3)

Publication Number Publication Date
EE200000429A EE200000429A (et) 2001-12-17
EE200000429A1 true EE200000429A1 (et) 2003-06-16
EE04157B1 EE04157B1 (et) 2003-10-15

Family

ID=9521914

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000429A EE04157B1 (et) 1998-01-19 1999-01-13 Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid

Country Status (41)

Country Link
US (1) US6528497B1 (et)
EP (1) EP1049721B1 (et)
JP (1) JP4402835B2 (et)
KR (1) KR100513196B1 (et)
CN (1) CN1165550C (et)
AR (1) AR013019A1 (et)
AT (1) ATE209219T1 (et)
AU (1) AU741748B2 (et)
BR (1) BRPI9907025B8 (et)
CA (1) CA2317465C (et)
CO (1) CO4970795A1 (et)
CZ (1) CZ297815B6 (et)
DE (1) DE69900718T2 (et)
DK (1) DK1049721T3 (et)
DZ (1) DZ2709A1 (et)
EE (1) EE04157B1 (et)
EG (1) EG23982A (et)
ES (1) ES2168000T3 (et)
FR (1) FR2773804B1 (et)
GT (1) GT199900003A (et)
HK (1) HK1030002A1 (et)
HR (1) HRP20000480B1 (et)
HU (1) HU228333B1 (et)
IL (1) IL137241A0 (et)
MA (1) MA26597A1 (et)
MY (1) MY119090A (et)
NO (1) NO329903B1 (et)
NZ (1) NZ505492A (et)
PE (1) PE20000269A1 (et)
PL (1) PL202802B1 (et)
PT (1) PT1049721E (et)
RU (1) RU2211224C2 (et)
SA (1) SA99191113B1 (et)
SI (1) SI1049721T1 (et)
SK (1) SK283411B6 (et)
TR (1) TR200002078T2 (et)
TW (1) TW548279B (et)
UA (1) UA60352C2 (et)
UY (1) UY25356A1 (et)
WO (1) WO1999036443A1 (et)
ZA (1) ZA99355B (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
WO2009130704A1 (en) * 2008-04-24 2009-10-29 Technion Research And Development Foundation Ltd. Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
KR101529061B1 (ko) 2008-05-30 2015-06-16 모멘타 파머슈티컬스 인코포레이티드 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
AU2010234779A1 (en) * 2009-03-30 2011-10-20 University Of Georgia Research Foundation, Inc. Heparan sulfate synthesis
CN105997864A (zh) 2009-07-09 2016-10-12 奥莎迪药品管理有限公司 基质载体组合物、方法及用途
CN104245718B (zh) 2009-07-31 2016-11-09 可靠生物医药公司 制备磺达肝素钠的方法及其合成中使用的中间体
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
JP2013537181A (ja) 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
US9005664B2 (en) 2010-10-17 2015-04-14 Technion Research And Development Foundation Ltd. Denatured lactoglobulin and polyphenol coassemblies
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
FR2749849B1 (fr) * 1996-06-14 1998-09-04 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
CZ427499A3 (cs) * 1998-05-29 2000-05-17 The Procter & Gamble Company Jemné topické antimikrobiální přípravky

Also Published As

Publication number Publication date
EE04157B1 (et) 2003-10-15
GT199900003A (es) 2000-07-07
MY119090A (en) 2005-03-31
BR9907025A (pt) 2000-10-17
CN1288470A (zh) 2001-03-21
DZ2709A1 (fr) 2003-09-01
ZA99355B (en) 2000-10-11
BRPI9907025B8 (pt) 2016-09-13
CA2317465A1 (en) 1999-07-22
US6528497B1 (en) 2003-03-04
HRP20000480A2 (en) 2000-12-31
DK1049721T3 (da) 2002-04-02
DE69900718D1 (de) 2002-02-21
WO1999036443A1 (fr) 1999-07-22
PL341875A1 (en) 2001-05-07
CZ297815B6 (cs) 2007-04-04
EP1049721B1 (fr) 2001-11-21
HUP0102009A1 (hu) 2001-11-28
HU228333B1 (en) 2013-03-28
TW548279B (en) 2003-08-21
JP4402835B2 (ja) 2010-01-20
HUP0102009A3 (en) 2003-07-28
UY25356A1 (es) 2000-10-31
EE200000429A (et) 2001-12-17
FR2773804B1 (fr) 2000-02-18
JP2002509164A (ja) 2002-03-26
CA2317465C (en) 2008-05-20
HK1030002A1 (en) 2001-04-20
PL202802B1 (pl) 2009-07-31
NO329903B1 (no) 2011-01-24
HRP20000480B1 (en) 2002-04-30
AR013019A1 (es) 2000-11-22
KR100513196B1 (ko) 2005-09-07
PT1049721E (pt) 2002-05-31
SI1049721T1 (en) 2002-06-30
CZ20002635A3 (cs) 2000-12-13
NO20003662L (no) 2000-09-14
RU2211224C2 (ru) 2003-08-27
AU1974599A (en) 1999-08-02
CN1165550C (zh) 2004-09-08
BR9907025B1 (pt) 2013-12-10
KR20010034189A (ko) 2001-04-25
NZ505492A (en) 2001-12-21
FR2773804A1 (fr) 1999-07-23
PE20000269A1 (es) 2000-06-15
TR200002078T2 (tr) 2000-11-21
SA99191113B1 (ar) 2006-10-11
SK10782000A3 (sk) 2001-02-12
EP1049721A1 (fr) 2000-11-08
EG23982A (en) 2008-02-27
AU741748B2 (en) 2001-12-06
ES2168000T3 (es) 2002-05-16
MA26597A1 (fr) 2004-12-20
UA60352C2 (uk) 2003-10-15
NO20003662D0 (no) 2000-07-17
IL137241A0 (en) 2001-07-24
DE69900718T2 (de) 2002-08-22
SK283411B6 (sk) 2003-07-01
CO4970795A1 (es) 2000-11-07
ATE209219T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
EE200000168A (et) Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200000791A (et) Uudsed atsüülpseudopeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200200138A (et) Kinolüülpropüülpiperidiini derivaadid, nende valmistamine ja neid sisaldavad kompositsioonid
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE04673B1 (et) Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid
EE9900015A (et) Sünteetilised polüsahhariidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE04779B1 (et) 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
EE04498B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon
EE200000613A (et) Kinoliini derivaadid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EE04276B1 (et) Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid
FI963566A0 (fi) Uusia piperatsiinijohdoksia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä koostumuksia
EE9700333A (et) Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid
EE200000429A (et) Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE9800426A (et) Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE200100027A (et) Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物
EE04348B1 (et) Sahhariidderivaadid, neid sisaldav farmatseutiline kompositsioon ja nende kasutamine
EE05004B1 (et) Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200000421A (et) Uued pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE03611B1 (et) Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine

Legal Events

Date Code Title Description
HH1A Change of representative
KB4A Valid patent at the end of a year

Effective date: 20031231

GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231